Impact of prior treatment with immune checkpoint inhibitors on dacarbazine efficacy in metastatic melanoma

被引：0
|
作者：
Sarah Bouchereau
Louise Chaplain
Magali Fort
Alain Beauchet
Thomas Sidibé
Marie Chapalain
Leire Gonzalez-Lara
Christine Longvert
Astrid Blom
Philippe Saiag
Elisa Funck-Brentano
机构：
[1] Ambroise Paré Hospital,Department of General and Oncologic Dermatology
[2] AP-HP,Department of Public Health
[3] Research unit EA4340 ‘Biomarkers and clinical trials in cancerology and onco-hematology’,Department of Pharmacy
[4] Versailles-Saint-Quentin-en-Yvelines University,undefined
[5] Paris-Saclay University,undefined
[6] GHU Paris-Saclay,undefined
[7] AP-HP,undefined
[8] Ambroise Paré Hospital,undefined
[9] AP-HP,undefined
来源：
British Journal of Cancer | 2021年 / 125卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：948 / 954
页数：6
相关论文
共 50 条
  • [1] Impact of prior treatment with immune checkpoint inhibitors on dacarbazine efficacy in metastatic melanoma
    Bouchereau, Sarah
    Chaplain, Louise
    Fort, Magali
    Beauchet, Alain
    Sidibe, Thomas
    Chapalain, Marie
    Gonzalez-Lara, Leire
    Longvert, Christine
    Blom, Astrid
    Saiag, Philippe
    Funck-Brentano, Elisa
    BRITISH JOURNAL OF CANCER, 2021, 125 (07) : 948 - 954
  • [2] Immune Checkpoint Inhibitors in the Treatment of Metastatic Melanoma
    Mier, James W.
    CLINICAL THERAPEUTICS, 2015, 37 (04) : 753 - 754
  • [3] Immune Checkpoint Inhibitors in the Treatment of Metastatic Uveal Melanoma
    Kuo, J. C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 60 - 61
  • [4] Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma
    Wong, Selina K.
    Blum, Steven M.
    Sun, Xiaopeng
    Silva, Ines P. Da
    Zubiri, Leyre
    Ye, Fei
    Bai, Kun
    Zhang, Kevin
    Ugurel, Selma
    Zimmer, Lisa
    Livingstone, Elisabeth
    Schadendorf, Dirk
    Serra-Bellver, Patricio
    Munoz-Couselo, Eva
    Ortiz, Carolina
    Lostes, Julia
    Huertas, Roberto M.
    Arance, Ana
    Pickering, Lisa
    V. Long, Georgina
    Carlino, Matteo S.
    Buchbinder, Elizabeth I.
    Vazquez-Cortes, Leticia
    Jara-Casas, Diego
    Marquez-Rodas, Ivan
    Gonzalez-Espinoza, Ivan R.
    Balko, Justin M.
    Menzies, Alexander M.
    Sullivan, Ryan J.
    Johnson, Douglas B.
    EUROPEAN JOURNAL OF CANCER, 2023, 181 : 188 - 197
  • [5] Enhanced dacarbazine efficacy in advanced melanoma patients previously treated with immune checkpoint inhibitors in Korea
    Lee, Soo Jung
    Na, Jihyun
    Lee, In Hee
    Lee, Jeeyeon
    Lee, Seok-Jong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
    Teresa Kim
    Rodabe NAmaria
    Christine Spencer
    Alexandre Reuben
    Zachary ACooper
    Jennifer AWargo
    Cancer Biology & Medicine, 2014, 11 (04) : 237 - 246+213
  • [7] Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
    Teresa Kim
    Rodabe N.Amaria
    Christine Spencer
    Alexandre Reuben
    Zachary A.Cooper
    Jennifer A.Wargo
    Cancer Biology & Medicine, 2014, (04) : 237 - 246
  • [8] Immune Checkpoint Inhibitors for Treatment of Metastatic Melanoma of the Orbit and Ocular Adnexa
    Ford, Joshua
    Thuro, Bradley A.
    Thakar, Sudip
    Hwu, Wen-Jen
    Richani, Karina
    Esmaeli, Bita
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2017, 33 (04): : E82 - E85
  • [9] Immune checkpoint inhibitors for the treatment of melanoma
    Sabbatino, Francesco
    Liguori, Luigi
    Pepe, Stefano
    Ferrone, Soldano
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (05) : 563 - 576
  • [10] Real-world impact of immune checkpoint inhibitors in metastatic uveal melanoma
    Bol, K. F.
    Ellebaek, E.
    Donia, M.
    Schmidt, H.
    Bastholt, L.
    Kiilgaard, J. F.
    Svane, I-M.
    ANNALS OF ONCOLOGY, 2019, 30 : 539 - 539
12345